US FDA approves Celcuity's breast cancer drug - Reuters
US FDA approves Celcuity's breast cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOVlQwdGFBOVJZNDBha3U3SkdCaF9hOHE4QmxPR2YzVXdIT2ZBM3FNbG8ycHJMSVVVNHZhOHdoRU1iekp0QnowME0zMkhWdGlkdzItMF80eVNRVklWOXFUeVI3QjF4ckRoS3BFTHdLaFo3UkxNZElGQjBzNVJCajJwZHZCQzE2N2JhTDlZM0RTX2ZOXzZHNjVDU0N1TGMzQzNPaHo4enFfd191eVNuVEFMaWprZnRXQ0k?oc=5" target="_blank">US FDA approves Celcuity's breast cancer drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters
US FDA approves Sanofi's wearable injector form of blood cancer drug Reuters
July 10, 2026 at 05:49 PMUS FDA approves Vera's kidney disease drug - Reuters
US FDA approves Vera's kidney disease drug Reuters
July 7, 2026 at 05:09 PMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PMGSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters
July 13, 2026 at 06:45 PMGSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
July 10, 2026 at 01:46 PMFDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
July 13, 2026 at 08:59 PM